Find drug development pipeline and deal Updates information

Lead Product(s): Quetiapine Fumarate

Therapeutic Area: Psychiatry/Psychology

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Cipla Medpro

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement February 10, 2020

Details:

Luye Pharma granted the distribution and marketing rights to Cipla Medpro in South Africa and neighbouring countries on the basis of its robust business network and resources in local markets.